When fatal heroin overdose is suspected, blood samples are traditionally analyzed by GC/MS, after extraction and derivatization, to determine the active metabolites 6-MAM and morphine. This method allows also to perform a so known “generic investigation” of the basic compounds, including impurities and cutting agents of “street heroin”, such as acetylcodeine and its metabolite codeine. The concentration of morphine in blood is usually the most important analytical result for the interpretation of the cause of death [1]. However, a number of overdose fatalities show relatively low blood concentrations of morphine, i.e. below or similar to those of living consumers or intoxicated heroin users [2]. This could be due to a variety of reasons, such as the relationship between lethal dose and current individual tolerance [3], the complexity of heroin metabolism, the presence of systemic dysfunction and the contemporary use of other drugs of abuse. Moreover, post-mortem redistribution or drug instability can affect the concentration of drugs in blood [4]. In post-mortem forensic toxicology the analysis of brain specimens may be also useful. Indeed, the sites of action of heroin and its main metabolites are primarily located in the central nervous system, so that concentrations in post-mortem brain samples are close or equal to those responsible for the toxic effects which caused death. Brain distribution pattern of “street” heroin metabolites (morphine and codeine) was investigated in two fatalities due to “acute narcotism” [5]. A suitable sample pretreatment prior to solid-phase-extraction was developed to achieve a good recovery of the analytes and to eliminate interfering species. After derivatization with MSTFA, samples were analyzed by GC/MS. Specificity, accuracy, precision and linearity of the method were evaluated. This method was applied to the analysis of six brain areas (hippocampus, frontal lobe, occipital lobe, nuclei, bulb and pons) coming from the two cases of heroin-related deaths. No evidence of accumulation of metabolites in a specific brain region was found, so bulb, which is the specimen that is usually taken during an autopsy, can be considered as representative of the drug concentration in the whole brain. Subsequently, the concentration of morphine and codeine in brain was investigated in fourteen samples belonging to cases of suspected fatal heroin overdose. Results were compared to those coming from the analysis of blood specimens. No correlation was found between the concentrations of morphine and codeine in blood and brain, but a higher ratio between codeine and morphine was found in brain, suggesting an accumulation and/or a slower metabolism of this more hydrophobic derivative in that compartment.

Disposition of morphine and codeine in blood and in brain samples in cases of fatal heroin overdose / V. Gambaro, K. Guerrini, A. Argo, L. Dell'Acqua, F. Farè, G. Roda, R. Froldi, P. Procaccianti - In: Atti del 24th International Symposium on Pharmaceutical and Biomedical Analysis PBA 2013 : recent developments in pharmaceutical analysis (RDPA 2013) , Palazzo Gnudi Scagliarini, Bologna 2013[s.l] : PBA2013, 2013 Jul 03. - pp. OC48-OC48 (( Intervento presentato al 24. convegno International symposium on pharmaceutical and biomedical analysis (PBA) tenutosi a Bologna nel 2013.

Disposition of morphine and codeine in blood and in brain samples in cases of fatal heroin overdose

V. Gambaro
Primo
;
K. Guerrini
Secondo
;
L. Dell'Acqua;F. Farè;G. Roda
;
2013

Abstract

When fatal heroin overdose is suspected, blood samples are traditionally analyzed by GC/MS, after extraction and derivatization, to determine the active metabolites 6-MAM and morphine. This method allows also to perform a so known “generic investigation” of the basic compounds, including impurities and cutting agents of “street heroin”, such as acetylcodeine and its metabolite codeine. The concentration of morphine in blood is usually the most important analytical result for the interpretation of the cause of death [1]. However, a number of overdose fatalities show relatively low blood concentrations of morphine, i.e. below or similar to those of living consumers or intoxicated heroin users [2]. This could be due to a variety of reasons, such as the relationship between lethal dose and current individual tolerance [3], the complexity of heroin metabolism, the presence of systemic dysfunction and the contemporary use of other drugs of abuse. Moreover, post-mortem redistribution or drug instability can affect the concentration of drugs in blood [4]. In post-mortem forensic toxicology the analysis of brain specimens may be also useful. Indeed, the sites of action of heroin and its main metabolites are primarily located in the central nervous system, so that concentrations in post-mortem brain samples are close or equal to those responsible for the toxic effects which caused death. Brain distribution pattern of “street” heroin metabolites (morphine and codeine) was investigated in two fatalities due to “acute narcotism” [5]. A suitable sample pretreatment prior to solid-phase-extraction was developed to achieve a good recovery of the analytes and to eliminate interfering species. After derivatization with MSTFA, samples were analyzed by GC/MS. Specificity, accuracy, precision and linearity of the method were evaluated. This method was applied to the analysis of six brain areas (hippocampus, frontal lobe, occipital lobe, nuclei, bulb and pons) coming from the two cases of heroin-related deaths. No evidence of accumulation of metabolites in a specific brain region was found, so bulb, which is the specimen that is usually taken during an autopsy, can be considered as representative of the drug concentration in the whole brain. Subsequently, the concentration of morphine and codeine in brain was investigated in fourteen samples belonging to cases of suspected fatal heroin overdose. Results were compared to those coming from the analysis of blood specimens. No correlation was found between the concentrations of morphine and codeine in blood and brain, but a higher ratio between codeine and morphine was found in brain, suggesting an accumulation and/or a slower metabolism of this more hydrophobic derivative in that compartment.
Settore CHIM/08 - Chimica Farmaceutica
3-lug-2013
Book Part (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/260541
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact